Semperit Investor Presentation, Financial year 2012

March / April 2013

FINANCIAL YEAR 2012 SEMPERIT GROUP INVESTOR PRESENTATION

Key Highlights Financial Year 2012

Semperit Group Revenue by regions

Semperit Group Revenue by segments

Sempermed 46%

Semperform 15%

Semper- trans 17%

Semperflex 22%

Europe 58%

Asia, Africa, RoW 16%

North- & South-America 26%

Investor Presentation I Financial Year 2012 I March / April 2013 2

Medical Sector: Entering a new phase of global growth

Industrial Sector: Best year in company history

• Takeover of Latexx Partners as strategic milestone • Revenue increased through acquisition • Decline in results due to price pressure caused by

excess capacity and competition

• Record revenue of EUR 828.6m in 2012 • Average growth rate of 9.6% from 2010 to 2012 • EBITDA with EUR 108.7m slightly below 2011 • Second best net result in company history (EUR 46.2m) • High cash and cash equivalents of EUR 133.3m • Unchanged dividend for 2012: EUR 0.80/share (proposal)

• Increase in market shares due to focus on core products, optimisation measures and investments

• Positive development in all segments despite difficult market environment

• High margins and best sector performance ever

Semperit on growth path

Challenging market environment

• Raw materials marked by volatile price developments

• Prices for natural rubber around 10% below 2011

• Synthetic rubber started with significant price increase and was at the end of 2012 around 10% below 2011

Medical Sector • Medical gloves market mostly non-cyclical • Pricing pressure due to overcapacities and competition

Industrial Sector • Relevant customer industries (energy, construction or

engineering) were influenced by weak economic cycle

• Semperit achieved excellent profitability despite this challenging environment

Macroeconomic downturn

Decreasing prices for raw materials

Impact on Semperit Group

• Slowdown of world economy, “Euro crisis”

• Weaker demand for investment goods and consumer durables

3

GDP growth in %

Growing global gloves market in bn pieces

1.5% 1.8%

9.3%

-0.4%

2.2%

7.9%

-0.1%

1.9%

8.4%

-2.0%

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

Eurozone USA China

2011 2012 2013e

150

200

2010 2015Sources: World Bank, Semperit Group estimates

Investor Presentation I Financial Year 2012 I March / April 2013

Operational Performance

10% volume growth including Latexx Partners, price decrease due to excess capacities and raw material prices

Revenue increased by 3% due to Latexx Partners acquisition

One-time effects in Thailand (storm damage, higher energy prices, start up costs in Surat Thani) put a strain on results/margins

Sempermed Syntegra UV surgical glove

Sempercare Nitrile Aloe examination glove

Business development

Product innovations

Office in Singapore

Worldwide management of glove business

Proximity to market, production and clients

Key Financials Sempermed

Sempermed 2012: Entering a new phase of global growth

5

* 2011 adjusted, see notes of annual report

in EUR m 2012 2011* change

Revenue 383.5 371.5 +3.2%

EBITDA 41.5 44.4 -6.5%

EBITDA margin 10.8% 12.0% -1.2 pp

EBIT 27.6 34.4 -19.8%

EBIT margin 7.2% 9.3% -2.1 pp


Weak global market development

European and US markets performed better than Asia

High inventory levels in the Chinese engineering sector led to weak demand in Southeast-Asia

Increase in market share and further capacity investments

Positive price effects in all business units

Lower volumes (industrial hoses and elastomer sheeting)

Improved results through optimised resources management

Market



Revenue 180.6 186.9 -3.4%

EBITDA 38.6 35.2 +9.7%

EBITDA margin 21.4% 18.8% +2.6 pp

EBIT 27.6 24.5 +12.5%

EBIT margin 15.3% 13.1% +2.2 pp

Key Financials Semperflex

Semperflex 2012: Outstanding results

6



Stable and long-lasting market growth driven by global market trends and project business

Growth rates of about 2-3% per year

Successful positioning as an alternative to other big suppliers and improved product mix

Further globalisation progress with success stories in South America/Chile and projects in Africa

Significantly optimised resources management

Substantial results- and margin improvement

Market



Revenue 143.8 147.0 -2.2%

EBITDA 21.2 14.4 +47.0%

EBITDA margin 14.7% 9.8% +4.9 pp

EBIT 16.0 10.8 +47.5%

EBIT margin 11.1% 7.4% +4.7 pp

Key Financials Sempertrans

Sempertrans 2012: Continous earnings improvement

7



Difficult market for construction profiles (weak construction industry)

Stable demand for ropeway liners and ski foils

Growth in handrails but aggressive pricing situation

Positive business development in nearly all business units

Volume increase in construction profiles and handrails

Earnings without one-time effects at same level

Market



Revenue 120.7 114.6 +5.4%

EBITDA 20.4 23.6 -13.4%


EBIT 14.6 18.2 -19.6%

EBIT margin 12.1% 15.9% -3.8 pp

Key Financials Semperform

Semperform 2012: Stable development

8



Financial Performance

2012 2011* %

383.5 371.5 +3.2%

41.5 44.4 -6.5%

10.8% 12.0% -1.2 pp

27.6 34.4 -19.8%

7.2% 9.3% -2.1 pp

5,265 4,834 +8.9%

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Employees (avg.)

Medical Sector Industrial Sector

2012 2011* %

445.1 448.5 -0.8%

80.2 73.2 +9.6%

18.0% 16.3% +1.7 pp

58.2 53.5 +8.7%

13.1% 11.9% +1.2 pp

2,986 2,967 +0.6%

2012 2011* %

828.6 820.0 +1.0%

108.7 110.0 -1.3%

13.1% 13.4% -0.3 pp

72.5 80.4 -9.8%

8.8% 9.8% -1.0 pp

8,305 7,833 +6.0%


2012 driven by strong Industrial Sector

10

Group Total


Industrial Sector: profitability increase

11

Semperflex

Sempertrans

Semperform

Strong profit growth despite economic slowdown

Weaker demand in Asia

Improved raw material management and production planning

Significant profit and margin improvement

Strike in India shadows revenue

Product mix optimisation

Earnings on like-for-like basis at 2011 level

Strong revenue in construction profiles and handrails

Optimisation of compound mix continues


Revenue 180.6 186.9 -3.4%

EBIT 27.6 24.5 +12.5%

EBIT margin 15.3% 13.1% +2.2 pp


Revenue 143.8 147.0 -2.2%

EBIT in EUR m 16.0 10.8 +47.5%

EBIT margin 11.1% 7.4% +3.7 pp


Revenue 120.7 114.6 +5.4

EBIT in EUR m 14.6 18.2 -19.6%

EBIT margin 12.1% 15.9% -3.8 pp

Sustainable improvement of results in the Industrial Sector



10.6 11.2 11.5 12.3 13.5

02468

10121416

2008 2009 2010 2011 2012

Medical Sector: Revenue growth in highly competitive markets

12


Revenue 383.5 371.5 +3.2%

thereof Latexx Part. 14.5 – –

EBITDA 41.5 44.4 -6.5%


Depreciation -13.9 -10.0 +39.2%

EBIT 27.6 34.4 -19.8%

EBIT margin 7.2% 9.3% -2.2 pp

Sales increase but price decline

Significant volume increase: +10%

Increase in revenue by 3.2%

Negative pricing effect driven by lower raw material prices

Double digit EBITDA margin

EBIT also impacted by higher depreciation

Key Financials Sempermed

Sales of examination gloves in bn pieces

+ 9.8%



Excellent liquidity

13

• High cash and cash equivalents of EUR 133.3m by

end of 2012

• Significant improvement of the cash flow from trade

working capital

• Cash flow from financing activities increased from

EUR -24.4m in 2011 to EUR 80.7m in 2012, initiated

by loan agreement and reduced dividend payment

• Cash flow from investing activities increased to

EUR -151.6m, driven by Latexx Partners acquisition

Highlights 2012

+ 36%

Cash and cash equivalents in EUR m

97.9

133.3

0

20

40

60

80

100

120

140

31.12.2011 31.12.2012


Superior financial stability

14


Total assets 824.5 616.7 +33.7%

Equity1) 406.2 379.4 +7.1%

Equity ratio 49.3% 61.5% -12.2 pp


Cash and cash equiv. 133.3 97.9 +36.2%

Bank liabilities 118.5 6.2 +112.3m

Net liquidity 14.8 91.7 -79.9m

2012 2011* change

Dividend proposal (EUR) 0.80 0.80 –

Payout ratio 35.6% 31.7% +3.9 pp

Total amount (EUR m) 16.5 16.5 –

High financial stability even after groundbreaking company acquisition

Strong positive net liquidity

Unchanged dividend

* 2011 adjusted, see notes of annual report 1) excl. non-controlling interests


Integration of Latexx Partners

15

Payment of purchase price of EUR 131m (100% investment would be 153.3m)

Bank financing of EUR 100.0m

Acquisition cost in 2012 of EUR 4m

Goodwill after purchase price allocation of EUR 97.6m

Non-controlling interests (minorities) of EUR 22.3m

Latexx Partners is being consolidated since November 2012

Sales contribution of EUR 15m in November and December 2012

Consolidation of Latexx Partners

Financial effects


Investments in maintenance and growth

• Sempermed: New line in Surat Thani completed • Semperflex: Maintenance and growth

investments in Austria, Czech Republic, Thailand and China

Capital expenditure

Projects completed in 2012

CAPEX 2013

• CAPEX of EUR 50m planned in 2013 • Thereof 50% in maintenance,

50% in growth projects

CAPEX and Depreciation 2010-2012 in EUR m

16

• Total CAPEX of EUR 41.2m after EUR 45.1m in 2011

• CAPEX to depreciation ratio down to 1.1x from 1.5x in 2011

52.5 45.1

41.2

29.9 29.7 36.2

0

10

20

30

40

50

60

2010 2011 2012

Investments Depreciation


Outlook

Sempermed Semperflex Sempertrans Semperform

Medical Sector Industrial Sector

Focus on Latexx Partners integration • Combined raw material sourcing and procurement

• Cross-selling sales

• Increase of utilisation

• Programme for energy efficiency

Increase market share • Market remains difficult

• Sales and marketing activities in growing markets

• Focus on expansion in Americas and Asia

Growth by new products and markets • Unchanged stable market

• New, innovative products

• Further optimisation of production & distribution

Stable Development • Stable market environment

• Compensation of pricing pressure by excess volumes

• Consolidation of products

Further growth due to Latexx Partners integration Continued pricing pressure in Medical Sector Industrial business will face challenges Stable year 2013 expected

2013 – a stable year expected

18 Investor Presentation I Financial Year 2012 I March / April 2013

Outlook

Unchanged growth targets

Investments and Dividends

• Average double digit growth from 2010-2015 (CAGR) • EBITDA margin of 12 - 15% • EBIT margin of 8 - 11 %

• Unchanged economic situation in first half of 2013 • Brightening of the market and demand stimulation in Q2 2013 expected at the earliest

• CAPEX of EUR 50m in maintenance and growth • Dividend: unchanged payout ratio of about 30%

Market view


Contact

Investor Relations

[email protected]

+43 1 79777 - 210

www.semperitgroup.com/en/ir

Modecenterstrasse 22

1031 Vienna, Austria

Financial calendar 2013 of Semperit April 30, 2013 Annual General Meeting, Vienna May 7, 2013 Ex-Dividend Day May 14, 2013 Dividend Payment Day May 14, 2013 Report on Q1 2013 August 13, 2013 Report on H1 2013 November 12, 2013 Report on Q1-3 2013


Disclaimer

The information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submit an offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes. The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared. As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements.


APPENDIX

Highlights 2012

Income statement: record in revenue, satisfying EBITDA

• Material costs down due to active raw material management and lower prices

• Personnel expenses and other operating expenses increased due to higher wages and acquisition costs Latexx Partners

• Increase in depreciation due to new capacities in Thailand and consolidation of Latexx Partners

• Tax rate declined to 16.7% after 18.6% in 2011

• Unchanged dividend proposal of EUR 0.80 per share: payout ratio 35.6% (2011: 31.7%)


Revenue 828.6 820.0 +1.0%

Other op. Income 32.8 33.8 -3.0%

Material costs -501.0 -513.1 -2.3%

Personell expenses -127.4 -117.9 +8.1%

Other op. expenses -124.2 -116.6 +6.5%

EBITDA 108.7 110.0 -1.3%

Depreciation -36.2 -29.7 +21.8%

EBIT 72.5 80.4 -9.8%

Financial Result -14.0 -13.4 +4.4%

EBT 58.5 66.9 -12.6%

Income taxes -12.2 -15.2 -19.3%

Earnings after tax 46.2 51.8 -10.7%

EPS (EUR) 2.25 2.52 -10.7%

DPS (EUR) 0.80 0.80 -

Key Figures Income Statement 2012 vs. 2011

23



Highlights 2012

Solid balance sheet structure

• Increase in total assets due to Latexx Partners consolidation

• Tangible fixed assets +23.6% to EUR 268m (2011: EUR 217m)

• Intangible assets increased from 6m to EUR 113m due to Latexx Partners acquistion

• Inventories and trade accounts receivables increased only due to Latexx Partners acquisition, effective trade working capital management

• Strong increase in equity due to positive result and non-controlling interests

• Increase in liabilities due to partial usage (EUR 100m) of a EUR 180m credit line


Fixed Assets 391.1 233.4 +67.5%

Inventories 142.5 137.6 +3.5%

Trade accounts receivable 120.2 114.3 +5.1%

Current assets incl. def. taxes 170.8 131.3 +30.1%

ASSETS 824.5 616.7 +33.7%

Key Figures Balance Sheet 2012 vs. 2011


Equity 428.0 379.4 +12.8%

Liablities from shares 110.1 97.3 +13.1%

Provisions incl. social capital 64.8 61.8 +4.9%

Other liablities incl. def. tax 221.6 78.2 >100%

EQUITY & LIABILITIES 824.5 616.7 +33.7%

24



Semperit Investor Presentation, Financial year 2012

Documents

best year

market shares

key highlights financial

company history eur

regions revenue

cash equivalents of

price pressure

best sector performance